Allergan Inc. Blog | Talkmarkets | Page 1
No data available
No data available

People who follow this stock (67)

Latest Posts

About This Stock More About This Stock
Allergan Reports Q2 Earnings Beat, Reaffirms Guidance
Article By: Benzinga
Tuesday, August 6, 2019 9:06 AM EDT
Allergan reported second-quarter earnings of $4.38 per share, which beat the analyst consensus estimate of $4.34 by 0.92%.
In this article: AGN
Read
Long Thesis For Allergan
Article By: ValueWalk
Sunday, July 14, 2019 2:43 PM EDT
Quintessential Capital's Gabriel Grego recently shared a rare long call for Allergan. This is interesting not only because AGN was once a hot short position due to Bill Ackman, but also because Grego is known for his shorts.
In this article: AGN
Read
3 Dividend Stocks Retirees Must Have In Their Portfolio
Article By: SureDividend
Sunday, July 7, 2019 2:18 AM EDT
Investing in strong dividend growers will help you live a stress-free retirement. Even if we are currently trading at an all-time high, Mr. Market offers us a few great opportunities. Here are my favorites right now.
In this article: ABT, AGN, ENB, LAZ, ABBV
Read
E American Depositary Receipts
Article By: Vivian Lewis
Thursday, June 27, 2019 12:01 AM EDT
The medical devices firm Smith & Nephew pondered creating an ADR listing in order to pay their new CEO Narnal Nawana a higher salary than would have been tolerated by UK shareholders. And more on global stocks.
In this article: ANFGF, CRH, GNCGY, MELI, NPSNY, TCEHY, AAIGF, TEVA, AGN, ZYME, VOD, CGEN, GNFTF, BHC, BT, AQN, DCMYY, AZRE, FBASF, GLD
Read
Abbvie To Buy Allergan For $60 Billion In Latest Pharma Megadeal
Article By: Tyler Durden
Tuesday, June 25, 2019 7:14 AM EDT
Abbvie will pay most of the price, represents a 45% premium over Allergan’s closing share price Monday of $129.57, in cash.
In this article: ABBV, AGN
Read

PARTNER HEADLINES

Latest Tweets for $AGN

No tweets yet!

$AGN

Patent Losses Could Sink Allergan
Dean Gilmore 2/5/2018 2:37:30 PM

Look at where $AGN was a year ago. It has lost a chunk of it's value already. This news won't help.

Patent Losses Could Sink Allergan
Alpha Stockman 2/5/2018 2:26:42 PM

These hits all hurt #Allergan's bottom line but aren't it's cash cows like #Botox which still does very well for the company and will only only generate even more revenue over time. $AGN

Patent Losses Could Sink Allergan
Ayelet Wolf 2/5/2018 2:22:51 PM

This news sounds catastrophic to me. Why isn't #Allergan tanking? $AGN

Valeant Edges Up 15% After Announcing That It Will Acquire Salix
Terry Caruso 2/24/2015 8:20:44 PM

You said the company tried to acquire Allergan but the deal fell through because Valeant didn't like it's large R&D program. If true, why did it try to acquire $AGN in the first place?

1 to 4 of 4 comments